Cytosorbents Crp Valuation
| CTSO Stock | USD 0.97 0.06 6.59% |
Today, the firm appears to be undervalued. Cytosorbents Crp shows a prevailing Real Value of $2.62 per share. The current price of the firm is $0.97. Our model approximates the value of Cytosorbents Crp from analyzing the firm fundamentals such as Profit Margin of (0.49) %, return on equity of -1.18, and Current Valuation of 74.16 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cytosorbents Crp's valuation include:
Price Book 4.0802 | Enterprise Value 74.2 M | Enterprise Value Ebitda (1.92) | Price Sales 1.4054 | Forward PE 7.734 |
Undervalued
Today
Please note that Cytosorbents Crp's price fluctuation is dangerous at this time. Calculation of the real value of Cytosorbents Crp is based on 3 months time horizon. Increasing Cytosorbents Crp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cytosorbents Crp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cytosorbents Stock. However, Cytosorbents Crp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.97 | Real 2.62 | Target 7.67 | Hype 0.97 |
The intrinsic value of Cytosorbents Crp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cytosorbents Crp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cytosorbents Crp helps investors to forecast how Cytosorbents stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cytosorbents Crp more accurately as focusing exclusively on Cytosorbents Crp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cytosorbents Crp's intrinsic value based on its ongoing forecasts of Cytosorbents Crp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cytosorbents Crp's closest peers.
Cytosorbents Crp Cash |
|
Cytosorbents Valuation Trend
Knowing Cytosorbents Crp's actual value is paramount for traders when making sound investment determinations. Using both Cytosorbents Crp's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Cytosorbents Crp Total Value Analysis
Cytosorbents Crp is currently projected to have valuation of 74.16 M with market capitalization of 53.04 M, debt of 18.31 M, and cash on hands of 30.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cytosorbents Crp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
74.16 M | 53.04 M | 18.31 M | 30.16 M |
Cytosorbents Crp Investor Information
About 33.0% of the company shares are held by institutions such as insurance companies. The book value of Cytosorbents Crp was currently reported as 0.24. The company recorded a loss per share of 0.36. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014. Based on the analysis of Cytosorbents Crp's profitability, liquidity, and operating efficiency, Cytosorbents Crp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Cytosorbents Crp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cytosorbents Crp has an asset utilization ratio of 68.25 percent. This suggests that the Company is making $0.68 for each dollar of assets. An increasing asset utilization means that Cytosorbents Crp is more efficient with each dollar of assets it utilizes for everyday operations.Cytosorbents Crp Ownership Allocation
Cytosorbents Crp holds a total of 54.68 Million outstanding shares. 30% of Cytosorbents Crp outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cytosorbents Crp Profitability Analysis
The company reported the previous year's revenue of 36.35 M. Net Loss for the year was (28.51 M) with profit before overhead, payroll, taxes, and interest of 20.73 M.About Cytosorbents Crp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cytosorbents Crp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cytosorbents Crp based exclusively on its fundamental and basic technical indicators. By analyzing Cytosorbents Crp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cytosorbents Crp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytosorbents Crp. We calculate exposure to Cytosorbents Crp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cytosorbents Crp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 22.4 M | 11.6 M | |
| Pretax Profit Margin | (0.81) | (0.85) | |
| Operating Profit Margin | (0.86) | (0.90) | |
| Net Loss | (0.78) | (0.82) | |
| Gross Profit Margin | 0.62 | 0.65 |
Cytosorbents Crp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44.7 M | |
| Forward Price Earnings | 7.734 |
Cytosorbents Crp Current Valuation Indicators
Cytosorbents Crp's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cytosorbents Crp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cytosorbents Crp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cytosorbents Crp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cytosorbents Crp's worth.When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share 0.72 | Quarterly Revenue Growth 0.066 | Return On Assets (0.28) | Return On Equity (1.19) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.